Respiratory Failure and Non-Invasive Ventilation — Viva Defence

Opening statement (SASPOP, delivered aloud)

"Mr Webb is a 73-year-old retired carpenter with severe COPD, admitted with his second acidotic exacerbation requiring NIV this year, now recovering. His main problems are: advanced airflow obstruction with established ventilatory failure; a deteriorating exacerbation trajectory with two NIV admissions in four months; probable persistent hypercapnia needing post-discharge assessment for domiciliary NIV; the question of long-term oxygen; and the absence of any documented ceiling of care or advance care plan. I would like to complete his acute weaning safely, optimise his maintenance program, make the domiciliary decisions on evidence, and address goals of care while he is well." [1] [3]

Structured problem list

1. Severe COPD with type 2 ventilatory failure — FEV1 28% predicted; this admission's gas (pH 7.27, PaCO2 9.6) is acute-on-chronic hypercapnic failure, an NIV-indication exacerbation with trial-level evidence for reduced intubation and mortality [5].
2. Exacerbation trajectory — two acidotic admissions in four months marks a step-change in his disease course and a prognostic signal that must shape planning, not just treatment [1].
3. Probable persistent hypercapnia — if his PaCO2 remains above about 7 kPa at 2–4 weeks post-discharge he enters the HOT-HMV population, in which home NIV plus oxygen extended time to readmission or death versus oxygen alone [3].
4. Oxygen strategy — an at-risk CO2 retainer: controlled oxygen targeting 88–92% acutely, and formal LTOT assessment only when stable on room air [2] [4].
5. No documented escalation ceiling or advance care plan — after two NIV admissions this conversation is overdue, and it belongs in stability, not at 3 a.m. in the next crisis [1].
6. Function and support — lives alone; breathlessness-related anxiety and carer load on his daughter; pulmonary rehabilitation referral after discharge.

Integrated management plan

• Complete the acute episode safely: wean NIV in sessions as the pH normalises — meals and nebulisers off NIV, then nights only — with a gas after weaning to confirm stability; continue controlled oxygen to 88–92% [1] [2].
• Optimise the maintenance program: inhaler technique and escalation review, pulmonary rehabilitation after this hospitalised exacerbation, influenza and pneumococcal vaccination, smoking status revisited without judgement, and screening for comorbid heart failure and sleep apnoea overlap.
• Make the domiciliary decisions on evidence: repeat a room-air blood gas at 2–4 weeks post-discharge. Persistent hypercapnia above about 7 kPa → assess for home NIV on the HOT-HMV rationale, with the Köhnlein stable-hypercapnia survival data as supporting evidence; persistent hypoxaemia on air → formal LTOT assessment. The two therapies answer different problems and are selected independently [3] [6].
• Ceilings and advance care planning: an honest conversation about trajectory and about what NIV, ICU and intubation can and cannot offer him; document whether intubation is within his ceiling, record the discussion and his wishes, and complete an advance care plan — then give him and his daughter a written action plan for the next exacerbation, including controlled oxygen and early presentation [1].

Probing questions with model answers

"Why did this man need NIV, and what is the evidence?" — "His exacerbation produced a respiratory acidosis below pH 7.35 despite controlled oxygen and medical therapy — that is the trial-proven indication. Ward-based NIV in exactly this phenotype halved intubation and reduced in-hospital mortality in the Plant study, and the Cochrane meta-analysis confirms mortality and intubation benefits with a number needed to treat of about a dozen. The physiology is a fatiguing pump: IPAP rests the inspiratory muscles and clears CO2, EPAP offsets intrinsic PEEP" [5] [1].

"His daughter asks why he can't just have 'more oxygen' instead of the mask." — "Because his failure is ventilatory, not just oxygenation. Uncontrolled oxygen in a retainer like Mr Webb raises CO2 further — mostly by worsening V/Q matching and the Haldane effect — and in the prehospital RCT, titrated oxygen to 88–92% more than halved mortality compared with high-flow oxygen in COPD exacerbations. Oxygen treats the low sats; the mask treats the acidosis. He needs both, each at its own target" [4] [2].

"Would you send him home on NIV this time?" — "Not on today's information — I decide that on a room-air gas at 2–4 weeks, not on the admission gas. If he remains hypercapnic above about 7 kPa, he is the HOT-HMV population: home NIV with oxygen extended the time to readmission or death from about 1.4 to 4.3 months median. If his CO2 normalises, he is not — and I would not commit him to a machine without the phenotype, because the trial selected for persistent hypercapnia" [3].

"He tells you he never wants to go to ICU. How do you respond?" — "I would explore what he understands ICU to involve and what he fears — for many patients it is dying on a machine away from family. Then I would be honest: NIV on the ward remains available and works for his phenotype; intubation is a different commitment with real burdens at his severity. If after that he elects NIV as his ceiling, I document it explicitly — not for intubation, for full ward-based treatment including NIV — and record the discussion, his capacity, and who was present. That document protects him in both directions: he is not intubated against his wishes, and he is not denied wanted treatment by a night team guessing" [1].

"What single number will you act on at his post-discharge review?" — "The room-air PaCO2 at 2–4 weeks. Above about 7 kPa persistent, he is assessed for home NIV; below that, the HOT-HMV rationale does not apply. I would pair it with a room-air saturation assessment for LTOT — but the NIV decision hangs on the CO2" [3] [2].

Communication points

• Prognosis framing after a second NIV admission: honest about trajectory without removing hope — "your lungs are more fragile than a year ago, and the planning we do now is what keeps you at home longer" [1].
• Shared decision-making on home NIV: mask burden every night versus fewer readmissions — his priorities decide, informed by the HOT-HMV numbers [3].
• Involving his daughter as support (with his consent), including in the written exacerbation action plan and the advance care plan [1].